Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on firstname.lastname@example.org
The Partnering Agreements with Pharmacyclics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.
To Brows a Full Report with Toc: http://www.researchmoz.us/pharmacyclics-partnering-2009-2014-report.html
This report provides all the information you require to better understand Pharmacyclics and its partnering interests and activities over the past five years.
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.
The report will be delivered in PDF format within 3 working days of receipt of order. If CD-Rom version purchased, the report will be sent by courier using express service.
One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.
Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives.
The initial chapters of this report provide an orientation of big biotech's dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 lists the top 50 leading big biotech companies based on 2013 pharmaceutical revenues and their respective partnering activity.
Chapter 3 provides an overview of the leading partnering and M&A 2009 to present date based on headline value.
Chapter 4 provides details on how to approach big biotech companies with partnering opportunities whilst
Chapter 5 lists forthcoming partnering...